The Case for Stand-alone MIGS Gets Stronger

by Medscape • 2021/03/09 • 0 Comments

New data show meaningful reductions in IOP and medications in pseudophakic patients with open-angle-glaucoma.
Medscape Ophthalmology

← Visus Therapeutics Announces $36 Million Series A Financing to Advance Development of Novel Presbyopia-Correcting Eye Drop

New ZEISS AntiFOG Wipes Come to the Aid of Eyeglass Wearers Frustrated by Fogged Lenses Caused by Face Masks →